3 Tech Stocks under the radar – TNE, IRI, CGL


Below is a look at 3 technology stocks that have take some lead in terms of performance and other developments.

Technology One Limited (ASX: TNE) is an information technology stock which deals in Software Sales, Services, R&D and is also engaged in the development, marketing, implementation and support of enterprise business software solutions. TNE stock was trading at a market price of $4.980 (as at July 30, 2018) and has seen a daily price change of -$0.040 or a decline of -0.797% in terms of percentage. The annual dividend yield of the stock is 1.69% which is franked at 75.17%. Technology one is said to be capitalizing on its R&D spending (40 percent to 60 percent) compared to previous periods in which this amount was fully expensed, which would then be amortized into 3 to 5 years. Technology one said the transition to SaaS accounting would improve the predictability of earnings and simplify its accounts. Typically, accounting for 85 percent of earnings, the company will no longer have a bend towards the second half of the year and is no longer dependent on the license fees. The company has 99% retention rate with 1,200 clients. Company’s Annual Recurring Revenue (ARR) is growing at approximately 20% per annum. The guidance for FY19 at the start of the year is $189 million and is 80% of the total revenue; and for FY20, it is $229 million which is 83% of the total revenue.

Integrated Research Limited (ASX: IRI) is an information technology stock which caters to computer systems management products. IRI stock traded at a market price of $2.650 and has seen a daily price change of $0.050 and a percentage change or rise of 1.923%. The annual dividend yield of the stock is 2.5% which is fully franked. Integrated Research revealed that it had a disappointing result with revenue flat for the financial year and very small profit growth over the year. The board does not lack operational experience as Mr. Stephen J Killelea is the Chairman and Founder of the company. The company share has recovered as at July 30, 2018, and if we look at a 60 months period the company has seen a rise or a performance change of 150.00%. Integrated Research Limited has a market capitalization of $454.95 million.

The Citadel Group Limited (ASX: CGL) is also an information technology stock with technology services and vocational education and training provision. CGL stock traded at a market price of $7.030 with a daily price change of $0.040 and 0.572% in terms of percentage as at July 30, 2018. The annual dividend yield of the stock is 1.83% which is fully franked. Citadel has a market capitalization of $345.25 million, and to explore options for the business it is working with Investec Securities which has been quietly catching trade buyer and private equity interest in the Canberra-based business. Citadel, within a decade has been named as the 20th fastest growing private company in Australia which was formed in 2000 and got listed on ASX in 2014. In the last 12 months, the stock has seen a rise or a staggering performance change of 28.26%. The most recent acquisition of the company is Anesthetic Private Practice Pty Ltd for a transaction value of $1.51 million which was completed on April 27, 2018.

Given the developments, the three stocks have come under the radar of investors.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report